hmg coa antibody antibody - HMG CoAreductaseantibodymyositis HMG Understanding HMG-CoA Reductase Antibodies: Diagnosis and Implications

HMG CoAreductaseantibodymyositis The hmg coa antibody, specifically anti-HMG-CoA reductase antibodies (HMGCR), plays a critical role in diagnosing a rare but serious autoimmune condition known as necrotizing autoimmune myopathy (NAM). While these antibodies are generally considered rare in individuals using statins, their presence is a significant indicator of this myopathy. Research indicates that anti-HMG-CoA reductase antibodies are rare in statin users, yet can also be found in some individuals not receiving statins, highlighting the complexity of their diagnostic value.

HMG-CoA reductase, the enzyme targeted by these antibodies, is a vital protein involved in the cholesterol biosynthesis pathwayTreatment and outcomes in anti-HMG-CoA reductase- .... It is the rate-limiting enzyme in this process, meaning its activity dictates the overall speed of cholesterol productionNovus Biologicals Mouse HMG-CoA Reductase/HMGCR Antibody(CL0259) - BSA Free (NBP2-61616) is a monoclonal antibody validated for use in IHC and WB. All Novus .... This ubiquitously expressed glycoprotein is a transmembrane ER protein, functioning as a key regulator of cholesterol synthesis. Statins, a class of drugs commonly prescribed to lower cholesterol, exert their effect by inhibiting HMG-CoA reductase.Seropositivity for3-hydroxy-3-methylglutaryl-CoA reductase autoantibodiessupports the clinical diagnosis of necrotizing autoimmune myopathy (NAM). However, in some individuals, this inhibition can paradoxically trigger an autoimmune response.HMG CoA Reductase Antibody (Blood) Test

HMGCR autoantibodies have been identified as myositis-specific autoantibodies, strongly associating them with immune-mediated necrotizing myopathy.作者：JG Rademacher·2022·被引用次数：25—HMGCR-associated IMNM is a rare subset of myositis. With systemic treatment, patients usually achieve partial or complete remission. When HMGCR AAb positive patients present with progressive, irritable myopathy of the proximal muscles, it often presents with symptoms such as weakness and muscle discomfortAnti-HMGCR myopathy: clinical and histopathological.... Imaging studies like MRI may reveal edema, and laboratory tests frequently show a significantly elevated Creatinine Kinase level, often around 10 times the normal range.

The detection of antibodies against HMGCR is crucial for the diagnosis of necrotizing autoimmune myopathy (NAM). This allows for the targeted management of the condition. While statin therapy can sometimes be implicated in the development of anti-HMGCR myopathy, it's important to note that this condition can persist even after statin cessation. In some cases, the autoimmune response may be triggered by statins, leading to the production of these antibodies and subsequent muscle damage, a phenomenon sometimes referred to as statin-induced necrotizing autoimmune myopathy with positive anti-HMG-CoA reductase antibodies.

For healthcare professionals and researchers, assays designed to detect the level of HMG-CoA reductase autoantibodies are invaluable tools. Companies like Novus Biologicals offer various HMG-CoA Reductase/HMGCR Antibody products, including the Novus Biologicals Mouse HMG-CoA Reductase/HMGCR Antibody and the HMG-CoA Reductase/HMGCR Antibody (6Y9L8), validated for different research applications such as Western Blotting and Immunohistochemistry (IHC). Other suppliers, like Biocompare, provide comprehensive antibody search and comparison tools to view specifications, prices, citations, reviews, suppliers, and more, facilitating research into this specific antibodyHMGCR Autoantibodies - Immunology Laboratory. The HMGCR antibody LS-B16059 is another example of a readily available polyclonal rabbit antibody.HMG-CoA reductase is a multitransmembrane ER proteinwith an N-terminal sterol-sensing domain (SSD; a.a. 61-218) and a C-terminal catalytic domain (a.a. 450-888) ...

The presence of HMGCR autoantibodies can also be associated with other myopathies. For instance, anti-HMGCR associated myopathy is recognized as a distinct form of immune-mediated necrotizing myopathy. This condition, also known as HMG-CoA myositis, is characterized by muscle inflammation and damage.作者：M Lavian·2017·被引用次数：11—We report a case of adult onset clinical dermatomyositis in a patient with previous statin use and positive anti-HMG-CoAreductaseantibodies. While specific treatments focus on managing the autoimmune response, the development of a clear understanding of the HMG-CoA reductase inhibitors' role in triggering or exacerbating this condition is an ongoing area of research.

In summary, hmg coa antibody testing is a specialized diagnostic approach for identifying necrotizing autoimmune myopathy. Understanding the role of HMG-CoA reductase in cholesterol synthesis and its interaction with the immune system, particularly in the context of statin use, is key to comprehending this complex condition. The availability of various antibody research tools and diagnostic assays continues to advance our knowledge and improve patient outcomesThe 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) enzymeis a ubiquitously expressed glycoproteinthat is bound to the membrane of the .... Efforts to fully understand the nuances of anti-HMG-CoA reductase myopathy and its treatment remain a priority in rheumatology and neurology.